By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Simvastatin

Simvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|643 words

What is Simvastatin?

Simvastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with high cholesterol or those at risk for heart disease. Simvastatin has been widely prescribed since its approval and is considered one of the most effective medications for managing cholesterol levels.

Uses

Simvastatin is approved for several cardiovascular-related conditions:

  • High cholesterol (hypercholesterolemia): Reduces elevated total cholesterol, LDL (“bad”) cholesterol, and triglycerides while modestly increasing HDL (“good”) cholesterol
  • Primary prevention of cardiovascular disease: Helps prevent heart attacks and strokes in patients with risk factors such as diabetes, high blood pressure, or family history of heart disease
  • Secondary prevention after cardiovascular events: Reduces the risk of future heart attacks, strokes, and other cardiovascular complications in patients who have already experienced these events
  • Mixed dyslipidemia: Treats patients with multiple lipid abnormalities, including elevated cholesterol and triglycerides
  • Familial hypercholesterolemia: Manages inherited conditions that cause extremely high cholesterol levels from birth

How it works

Simvastatin works by blocking an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. By inhibiting this enzyme, the medication significantly reduces the liver’s ability to manufacture cholesterol, forcing the body to remove cholesterol from the bloodstream to meet its needs. This mechanism effectively lowers blood cholesterol levels and reduces the buildup of fatty deposits in arteries.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Muscle pain or weakness
  • Headache
  • Nausea
  • Stomach pain or cramping
  • Constipation
  • Upper respiratory infections
  • Dizziness
  • Skin rash

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
  • Dark-colored urine
  • Yellowing of skin or eyes (jaundice)
  • Severe stomach pain
  • Unexplained fatigue or fever

Warnings and precautions

  • Liver function: Patients with active liver disease or unexplained elevated liver enzymes should not use simvastatin, as it can worsen liver problems
  • Pregnancy and breastfeeding: Simvastatin is contraindicated during pregnancy and breastfeeding, as cholesterol is essential for fetal development
  • Muscle problems: Risk of serious muscle damage increases with higher doses, advanced age, kidney disease, and certain drug combinations
  • Diabetes risk: Long-term statin use may slightly increase the risk of developing type 2 diabetes, particularly in patients with existing risk factors
  • Alcohol consumption: Patients should limit alcohol intake, as excessive alcohol combined with simvastatin can increase liver damage risk

Interactions

Simvastatin has numerous important drug interactions that can increase the risk of side effects:

  • Cyclosporine: Significantly increases simvastatin levels, raising muscle damage risk
  • Gemfibrozil and other fibrates: Combined use greatly increases the risk of muscle problems and rhabdomyolysis
  • Warfarin: Simvastatin may enhance anticoagulant effects, requiring closer monitoring of blood clotting times
  • Digoxin: May increase digoxin levels, potentially causing dangerous heart rhythm changes
  • Grapefruit juice: Large amounts can increase simvastatin concentrations and toxicity risk
  • Azole antifungals: Medications like itraconazole and ketoconazole can dramatically increase simvastatin levels
  • Macrolide antibiotics: Clarithromycin and erythromycin can increase the risk of muscle-related side effects
  • Protease inhibitors: HIV medications can significantly increase simvastatin concentrations

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages for simvastatin range from 5 mg to 40 mg taken once daily in the evening, with most patients starting at 10-20 mg daily. The maximum recommended dose is 40 mg daily, as higher doses significantly increase the risk of muscle damage without proportional benefits. Dosing may be adjusted based on cholesterol levels, cardiovascular risk factors, kidney function, and other medications. Patients should take simvastatin with or without food, preferably in the evening when cholesterol production is highest. All dosage decisions should be made by a healthcare provider who can assess individual patient factors and monitor for effectiveness and side effects.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Simvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/simvastatin-4/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Pitavastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026

Atorvastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up